Kell blood group, metallo-endopeptidase (KEL) is a gene that encodes a type II transmembrane glycoprotein, which is the highly polymorphic Kell blood group antigen. Missense mutations, synonymous mutations, and nonsense mutations are observed in cancers such as skin cancer, testicular cancer, and lung cancer.

Modified: January 7, 2016

Disclaimer: The information presented at is compiled from sources believed to be reliable. Extensive efforts have been made to make this information as accurate and as up-to-date as possible. However, the accuracy and completeness of this information cannot be guaranteed. Despite our best efforts, this information may contain typographical errors and omissions. The contents are to be used only as a guide, and health care providers should employ sound clinical judgment in interpreting this information for individual patient care.